Last Updated: August 9, 2026

Drug Price Trends for DERMA-SMOOTHE-FS SCALP OIL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for DERMA-SMOOTHE-FS SCALP OIL

Average Pharmacy Cost for DERMA-SMOOTHE-FS SCALP OIL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
DERMA-SMOOTHE-FS SCALP OIL 68791-0102-04 0.24227 ML 2026-04-01
DERMA-SMOOTHE-FS SCALP OIL 68791-0102-04 0.28070 ML 2026-03-18
DERMA-SMOOTHE-FS SCALP OIL 68791-0102-04 0.28133 ML 2026-02-18
DERMA-SMOOTHE-FS SCALP OIL 68791-0102-04 0.28134 ML 2026-01-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date
Last updated: February 17, 2026

What is DERMA-SMOOTHE-FS SCALP OIL?

DERMA-SMOOTHE-FS SCALP OIL is a topical dermatological product designed for scalp and hair health, marketed primarily for its claims to improve scalp condition and reduce hair loss. The product is available in select markets, with a formulation focusing on natural oils and active ingredients aimed at scalp nourishment.

What is the current market for scalp oils like DERMA-SMOOTHE-FS?

The global hair care market reached approximately $87 billion in 2022 and is projected to hit $122 billion by 2028, growing at a CAGR of 5.4% (1). The scalp care segment is a subset of this market, with increasing consumer interest driven by trends toward scalp health and natural ingredients.

In 2022, the scalp skincare segment was estimated at roughly $2 billion, representing a 10-12% share of the broader hair care market. Within this segment, products like scalp oils, serums, and shampoos dominate, with oral and topical treatments for hair loss also contributing.

Who are the main competitors?

Major competitors include:

  • Nioxin: Known for scalp treatment products targeting hair thinning.
  • Plantur: Focuses on caffeine-infused scalp products for women.
  • Rogaine (minoxidil formulations): Widely used for hair regrowth.
  • Burt’s Bees and The Honest Company: Offer natural scalp oils.

Market shares are fragmented, with no single dominant player in scalp oils specifically. Established brands hold 25-40% of the segment, with smaller brands and retailer private labels sharing the rest.

What are the key factors influencing product pricing?

Pricing is determined by:

  • Ingredient complexity and branding. Natural or organic claims can command premiums; DERMA-SMOOTHE-FS's proprietary formulation influences pricing.
  • Packaging size and delivery method. Common sizes range from 50ml to 200ml.
  • Distribution channels. Prices tend to be higher in specialty retail and direct-to-consumer channels.
  • Regulatory status. Tight controls on claims and marketing influence market positioning and pricing.

What are the current price ranges?

Pricing varies by market and channel, but typical retail prices for DERMA-SMOOTHE-FS SCALP OIL and comparable products in key markets are:

Market Price Range (USD) per 100ml Channels
US $25 - $45 Online, salons, drugstores
UK £18 - £35 Pharmacies, online
Canada CAD 30 - CAD 55 Pharmacies, online

In the US, natural scalp oils range from $20 to $40 per 100ml, depending on branding factors.

What are the projections for the product's pricing over the next five years?

Price trajectories depend on several factors:

  • Market growth: The scalp care segment is expected to expand at a 10% CAGR from 2023-2028.
  • Consumer preferences: Increased demand for natural and organic products could push prices upward.
  • Competitive landscape: Entry of new brands or private-label products at lower price points could pressure premiums.
  • Regulatory changes: Stricter claims regulations could impact product positioning and pricing.

Based on these factors, a conservative projection suggests:

  • In developed markets, prices could increase by 3-5% annually, reaching approximately $28-$47 per 100ml by 2028.
  • In emerging markets, price sensitivity may lead to stable or marginal increases of 1-2%, with prices around $20-$30 per 100ml.

What are the risks affecting future pricing?

Risks include:

  • Price competition from private labels and generic brands.
  • Market saturation leading to price wars.
  • Regulatory shifts limiting marketing claims.
  • Changes in consumer preferences toward alternative treatments or DIY solutions.

Key Takeaways

  • The scalp oil segment within hair care is growing, driven by consumer interest in scalp health.
  • DERMA-SMOOTHE-FS SCALP OIL’s pricing aligns with premium natural products, generally $25-$45 per 100ml in key markets.
  • Prices are expected to rise modestly in developed markets due to brand positioning and consumer demand for natural ingredients.
  • Market saturation and regulatory developments could exert downward pressure or complicate premium pricing strategies.
  • Competitive pressures from private labels and alternative treatments remain significant risks.

FAQs

1. How does DERMA-SMOOTHE-FS compare to similar products?
It focuses on natural ingredients with proprietary formulations, positioning it at the higher end of the scalp oil market.

2. What factors influence future demand for scalp oils?
Consumer awareness of scalp health, trends toward natural products, and product efficacy claims influence demand growth.

3. Are there regional differences in pricing?
Yes; pricing tends to be higher in developed markets like the US and UK due to consumer willingness to pay premiums for natural and branded products.

4. Will regulatory changes impact pricing?
Potentially. Stricter claims regulation could increase marketing costs or restrict claims, influencing final retail prices.

5. Is this segment susceptible to price wars?
Yes; lower-cost private labels and new entrants could lead to price competition, especially in highly saturated markets.

References

  1. Research and Markets. "Hair Care Market by Product Type, Distribution Channel, and Region - Global Forecast to 2028." 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.